DEBORAH GOREHAM: Open Payments
NPI 1083014559 · SONORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 20 payments from 8 companies in 2025. Trend: 2023 $67 · 2024 $272 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 9 | $178 |
| Novo Nordisk Inc | 3 | $83 |
| Lundbeck LLC | 2 | $63 |
| Lilly USA, LLC | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: Korlym, REXULTI, MOUNJARO, FANAPT, Rybelsus, Ozempic, Wegovy, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
